Lecanemab in Early Alzheimer's Disease.
N Engl J Med
; 388(1): 9-21, 2023 01 05.
Article
in En
| MEDLINE
| ID: mdl-36449413
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Nootropic Agents
/
Alzheimer Disease
/
Antibodies, Monoclonal, Humanized
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
N Engl J Med
Year:
2023
Document type:
Article
Country of publication:
Estados Unidos